Revalia Bio
PrivateLast Round
Grant
Dec 5, 2025
Total Funding Raised
$46.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Revalia Bio is a biotechnology company that provides a 'Human Data Trials' platform, enabling drug developers to test therapeutics on functional human organs obtained from deceased donors.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Biotech Equipment, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revalia Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Revalia Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 5, 2025 | ||||
| Seed | Sep 4, 2025 | ||||
| Pre Seed | Oct 17, 2024 |
Key People
Founding team and executive leadership
Revalia Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Seed, Pre Seed |
| Sierra Ventures | Seed |
| America's Frontier Fund | Seed |
| AFF | Seed |
| Pamir Ventures | Seed |
| BoxOne Ventures | Seed |
| ARPA-H | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Secured $30M in government contracts.
- Jan 1, 2026
Secured an ARPA-H award.
Revalia Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Revalia Bio's valuation, stock price, and market status.